Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.14M | -49.51M | -32.66M | -93.01M | -48.41M |
| Total Depreciation and Amortization | 60.02M | 49.92M | 50.60M | 48.28M | 56.09M |
| Total Amortization of Deferred Charges | 39.20M | 42.23M | 44.29M | 41.89M | 35.58M |
| Total Other Non-Cash Items | 9.56M | 32.61M | 15.75M | 59.25M | 31.90M |
| Change in Net Operating Assets | 4.10M | 24.01M | 13.45M | -40.49M | 10.74M |
| Cash from Operations | 87.74M | 99.26M | 91.43M | 15.92M | 85.90M |
| Capital Expenditure | -2.62M | -2.28M | -1.27M | -2.73M | -6.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -16.60M | -694.00K | -64.61M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.70M | -29.84M | -57.73M | -55.93M | -23.51M |
| Cash from Investing | -34.32M | -48.72M | -59.70M | -123.27M | -29.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -550.63M | -- | -- |
| Issuance of Common Stock | 1.10M | 517.00K | 696.00K | 769.00K | 1.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | -4.11M | -- | -- | 176.00K |
| Cash from Financing | 1.10M | -3.59M | -549.93M | 769.00K | 2.06M |
| Foreign Exchange rate Adjustments | 308.00K | -324.00K | 4.49M | 1.59M | -3.86M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.84M | 46.63M | -513.71M | -105.00M | 54.46M |